Kangwei (Guangzhou) Biotechnology Co.
Latest round
- Series A
Last raised
- Aug 2022
Total raised
- $46M
Investors
- 6
About Kangwei (Guangzhou) Biotechnology Co.
, Ltd operates as a manufacturer of anti-tumor drugs, focusing on providing cancer treatment drugs for patients. Its founding team has completed the research and development and FDA application of more than 50 new drugs, and clinical development of 40 new drugs. The company has established three technology platforms and a pipeline of new anti-tumor drugs, including immunotherapy platform, small molecule and coupling platform, and antibody drug coupling (ADC) platform. Its immunotherapy platform includes 2 clinical trial stage drugs, CAN1012 and DPV-001, which are therapeutic oncology vaccines.
Who invested in Kangwei (Guangzhou) Biotechnology Co.
6 investors across 2 rounds
See all investors in Kangwei (Guangzhou) Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kangwei (Guangzhou) Biotechnology Co.
Who invested in Kangwei (Guangzhou) Biotechnology Co.?
Kangwei (Guangzhou) Biotechnology Co. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kangwei (Guangzhou) Biotechnology Co. raised?
Kangwei (Guangzhou) Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kangwei (Guangzhou) Biotechnology Co. last raise money?
Kangwei (Guangzhou) Biotechnology Co.'s most recent round on record is a Series A, in Aug 2022.
What does Kangwei (Guangzhou) Biotechnology Co. do?
, Ltd operates as a manufacturer of anti-tumor drugs, focusing on providing cancer treatment drugs for patients.
Where is Kangwei (Guangzhou) Biotechnology Co. headquartered?
Kangwei (Guangzhou) Biotechnology Co. is headquartered in Guangzhou, China.
Which VCs invest in companies like Kangwei (Guangzhou) Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Kangwei (Guangzhou) Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kangwei (Guangzhou) Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.